United States Kidney Function Test Market, By Type (Urine Tests and Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited States Kidney Function Test Market, By Type (Urine Tests and Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2028
United States kidney function test market is expected to grow significantly over the coming years, due to major factors. These factors include the rising prevalence of chronic kidney diseases, increasing awareness about the importance of early diagnosis and treatment, and technological advancements in testing methods.
According to CDC (Centre for Disease Control and Prevention), more than 1 in 7, that is 15% of US adults or 37 million people, are estimated to have chronic kidney disease.
The importance of early kidney disease diagnosis and detection has resulted in a significant increase in public awareness. Frequent kidney function tests have been rapidly promoted by medical professionals and health organizations to identify problems with renal function early on. Early detection enables prompt care, which slows the progression of the disease and improves patient outcomes. The demand for kidney function testing has increased in the United States due to the focus on preventative healthcare treatments.
Kidney function tests have been revolutionized by advancements in diagnostic technologies and testing procedures. The efficiency, speed, and convenience of conducting these tests are all improving due to the development of automated analyzers and point-of-care testing equipment. Technological advancements have further accelerated the diagnosis process by providing effective data management and remote monitoring of patients' kidney function, such as the integration of electronic health records (EHRs) and telehealth services. These technological developments have improved kidney function test accessibility and price, spurring market expansion.
The market of kidney function testing has expanded substantially because of the ageing population in the United States. The kidney function of the elderly must be regularly monitored because they are more susceptible to renal disorders. It is expected that demand for kidney function testing would rise in parallel with the population's continued ageing trend.
The market of kidney function testing in the United States will face a few challenges, though. The constraints include high costs, restricted reimbursement, a lack of standards, low awareness, problems with diagnostic accuracy, slow adoption of cutting-edge technologies, and data privacy issues.
In kidney function tests, accuracy is crucial. Though, it is possible for test results to be inaccurate and provide false-positive or false-negative results. The interpretation of test findings may be impacted by various types of drugs, comorbidities, and dietary considerations, which may result in a false diagnosis or poor treatment options. To keep patients' and healthcare professionals' trust and confidence, it is essential to increase the precision of kidney function tests, reduce erroneous results, and create procedures that take confounding factors into account.
Data security and privacy are significant concerns because of the expanding usage of electronic health records (EHRs) and digital platforms for storing and sharing patient information. To ensure patient confidentiality, it is necessary to implement strong data protection procedures due to the sensitive nature of kidney function test results. To foster trust and promote the broad use of kidney function testing, strict data privacy legislation must be put in place, as well as secure information-sharing networks.
The field of diagnostics, especially kidney function testing, is undergoing a revolution due to the integration of artificial intelligence (AI) and machine learning (ML) technology. Large datasets can be analyzed by AI and ML systems, which can spot patterns that human observers would overlook. This innovative data analytics allows precise diagnostics, early kidney disease detection, and personalized therapy planning. The use of AI and ML in kidney function tests is expected to grow as they develop, improving diagnostic accuracy and efficacy.
The United States Food and Drug Administration (FDA) granted RenalytixAI approval for their new KidneyIntelX test in August 2020. Clinical trials utilizing AI aim to find patients with type 2 diabetes and fast deteriorating kidney conditions and to enhance their therapeutic care. Over the duration of the projected period, the introduction of technologically improved goods is expected to further drive the growth of the market.
Novel kidney function tests are being developed due to advancements in biomarker research. Traditional tests have drawbacks in terms of sensitivity and specificity, such as serum creatinine and blood urea nitrogen. Cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) are three biomarkers that have the potential to provide reliable assessments of kidney function and early indications of damage to the kidneys. The development of biomarker-based analyses will likely revolutionize the diagnosis of kidney function and enable accurate and timely detection of renal disorders.
Remote patient monitoring and telehealth services' adoption has been accelerated by the COVID-19 pandemic, and these developments are likely to escalate after the outbreak has passed. With the use of telehealth platforms, medical staff can remotely assess and monitor patients' kidney function, enabling prompt intervention and lowering the need for in-person visits. Medical professionals can provide individualized care and enhance treatment outcomes with the help of remote monitoring equipment and telehealth services, which provides real-time information on patients' kidney health.
Growing Prevalence of Chronic Kidney Diseases
The market of kidney function tests in the United States is expanding rapidly with the rising prevalence of chronic kidney diseases. A significant portion of the population is affected by chronic kidney disease (CKD), which has grown to be a major public health concern and imposes a heavy burden on healthcare systems as well. Since kidney function tests are crucial for the early detection, precise diagnosis, and efficient management of renal disorders, this rise in prevalence has increased the need for them.
The demand for diagnostic tests has increased because of the rise in chronic renal diseases. Kidney function tests are increasingly necessary to evaluate a person's renal health as more people are identified as having kidney ailments or are at increased risk for developing them. Serum creatinine, blood urea nitrogen, and estimated glomerular filtration rate (eGFR) are some examples of the tests that offer vital information on kidney function and aid in determining the existence and severity of kidney diseases. Demand for kidney function tests is directly influenced by the growing number of patients with renal diseases, which is a factor in the market's expansion.
To be able to effectively manage chronic kidney diseases, early detection and intervention are essential. Medical professionals and organizations are emphasizing kidney function tests more as part of regular health screenings because of a growing awareness of the significance of early diagnosis. Early detection enables prompt management and intervention, which can limit the spread of the disease and reduce complications. The need for kidney function tests is increasing as the incidence of renal illnesses rises and the value of early detection becomes increasingly evident.
Growing Prevalence of Underlying Conditions
The United States kidney function test market is expanding rapidly, despite the rising incidence of underlying diseases like diabetes and hypertension that cause complications in the kidneys. One of the main causes of chronic kidney disease (CKD) globally is diabetes, and the frequency of both conditions has been gradually rising. There is a growing need for renal function tests to identify and track kidney damage related to these underlying disorders as these conditions continue to become more prevalent in the United States.
The Centres for Disease Control and Prevention (CDC) reports that 37.3 million population of United States, or 11.3% of the population, have diabetes. There are 96 million adults in the United States who are pre-diabetic, or 38.0% of the adult population.
A significant risk factor for the development of CKD is diabetes. The prevalence of diabetic nephropathy, a form of kidney injury brought on by diabetes, has increased in tandem with the rising diabetes prevalence in the United States. To manage diabetic nephropathy and reduce the severity of CKD, early identification and routine kidney function monitoring are necessary. The market demand for kidney function tests is driven by the rising prevalence of diabetes and the growing understanding of the value of early detection.
Similarly, hypertension, or high blood pressure, is another important risk factor for renal diseases. Uncontrolled hypertension can cause the development of hypertensive nephropathy, a disorder characterized by kidney damage brought on by persistently high blood pressure. The need for routine renal function tests for detecting any early indicators of kidney disease is highlighted by the constantly increasing prevalence of hypertension in the United States.
Kidney function tests are crucial for identifying persons at risk and treating their renal health because diabetes, hypertension, and kidney disorders are all intertwined.
Download Free Sample Report
Market Segmentation
The United States kidney function test market can be segmented by type, component, end user, and region. By type, the United States kidney function test market can be segmented into urine tests and blood tests. Based on components, the United States kidney function test market is divided into dipsticks, reagents, kits & assays, and others. Based on end user, the United States kidney function test market is divided into hospitals & clinics, diagnostic laboratories, and others. Based on region, the United States Kidney function test market is divided into northeast region, midwest region, south region, and west region.
Market Players
Abbott Laboratories, Quest Diagnostics, LabCorp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and Sysmex Corporation are some of the leading companies operating in the United States kidney function test market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume Units, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
| Segments Covered | Type Component End User |
| Regional Scope | Northeast Region; Midwest Region; South Region; West Region |
| Key Companies Profiled | Abbott Laboratories, Quest Diagnostics, LabCorp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Corporation |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy